Modifications induced by oral clarithromycin and amoxicillin on interdigestive GI motility of patients with functional dyspepsia and H-pylori gastritis.

被引：0
|
作者：
Bortolotti, M [1 ]
Brunelli, F [1 ]
Sarti, P [1 ]
Romor, A [1 ]
Miglioli, M [1 ]
机构：
[1] Univ Bologna, Dept Internal Med & Gastroenterol, I-40126 Bologna, Italy
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80317-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0319
引用
收藏
页码：A78 / A79
页数：2
相关论文
共 31 条
  • [21] Prevalence of Active H-pylori Infection and Clarithromycin-Containing Triple Therapy Efficacy in Patients With Dyspepsia - Experience of a Tertiary Centre in North of Italy
    Furnari, Manuele
    Moscatelli, Alessandro
    Brunacci, Matteo
    Savarino, Edoardo
    Mazza, Fabrizio
    Del Nero, Lorenzo
    Gemignani, Lorenzo
    Giacchino, Maria
    Mastracci, Luca
    Savarino, Vincenzo
    GASTROENTEROLOGY, 2014, 146 (05) : S402 - S402
  • [22] Is there an association between gastric H-pylori colonization and duodenal motor response to nutrients in healthy subjects and patients with functional dyspepsia?
    Gschossmann, J
    Holtmann, G
    NeufangHuber, J
    Layer, P
    Goebell, H
    GASTROENTEROLOGY, 1996, 110 (04) : A672 - A672
  • [23] Characteristic of Helicobacter pylori induced gastritis and effect of H-pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-comparing to patients with peptic ulcer
    Ando, T
    Tsuzuki, T
    Mizuno, T
    Minami, M
    Ina, K
    Kusugami, K
    El-Omar, E
    Ohta, M
    Goto, H
    GASTROENTEROLOGY, 2004, 126 (04) : A182 - A182
  • [24] Does cure of H-pylori infection give different symptomatic response in patients with functional dyspepsia from different parts of the world?
    Bolling-Sternevald, E
    Talley, NJ
    Blum, A
    O'Morain, C
    Junghard, O
    Sundin, M
    Naesdal, J
    Glise, H
    GASTROENTEROLOGY, 1999, 116 (04) : A126 - A126
  • [25] Omeprazole or ranitidine bismuth citrate with clarithromycin and amoxicillin for 10 days to treat H-pylori infection: A randomized, controlled trial in Vietnamese patients with duodenal ulcer.
    Mao, HV
    Lak, BV
    Long, T
    Chung, NQ
    Thang, DM
    Hop, TV
    Chien, NN
    Hoan, PQ
    Henley, KS
    Connor, BA
    Stone, CD
    Chey, WD
    GASTROENTEROLOGY, 1999, 116 (04) : A136 - A136
  • [26] Efficacy of PPI-triple therapy in H-pylori (HP) positive patients with peptic ulcer disease versus patients with functional dyspepsia.
    Houben, MHMG
    Koops, HWS
    Rauws, EAJ
    Van 't Hoff, BWM
    Van der Hulst, RWM
    Van der Ende, A
    Ten Kate, FJW
    Tytgat, GNJ
    GASTROENTEROLOGY, 1999, 116 (04) : A190 - A190
  • [27] Eradication of H-pylori infection in patients with atrophic body gastritis (ABG) induced recovery of gastric acid secretion and decrease of gastrinemia
    Annibale, B
    Marignani, M
    Caruana, P
    Aprile, MR
    Mancino, C
    Martino, G
    Bordi, C
    DelleFave, G
    GASTROENTEROLOGY, 1997, 112 (04) : A59 - A59
  • [28] Quality of life in patients with H-pylori positive functional dyspepsia -: A one year follow up study after placebo controlled eradication therapy
    Koskenpato, J
    Färkkilä, M
    GUT, 1998, 43 : A110 - A110
  • [29] Quality of life in patients with functional dyspepsia:: Short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or Cisapride therapy:: A prospective, parallel-group study
    Buzas, Gyorgy M.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2006, 67 (05): : 305 - 320
  • [30] Absence of symptomatic benefit of lansoprazole, clarithromycin and amoxicillin (LCA) triple therapy is cure of Helicobacter pylori (Hp) positive functional dyspepsia (FD) patients. A randomized double-blind placebo-controlled trial
    van Zanten, SJV
    Fedorak, R
    Lambert, J
    Cohen, L
    Vanjaka, A
    GASTROENTEROLOGY, 2003, 124 (04) : A183 - A183
1234